Keyphrases
Virus
50%
Escape mutant
50%
Broadly Neutralizing
50%
Neutralizing mAbs
50%
Early-late
50%
HIV-1 Env
50%
Broadly Neutralizing Antibodies
50%
Human Immunodeficiency Virus Type 1 (HIV-1)
33%
AIDS/HIV
33%
Resistance Development
33%
Neutralizing Antibodies
33%
Escape Variants
33%
PG16
33%
Immunological Escape
33%
Acute HIV Infection
16%
Antibody Response
16%
Monoclonal Antibody
16%
Primary HIV Infection
16%
Virus Neutralization
16%
Epitope
16%
Chronic HIV Infection
16%
Rational Design
16%
Global Change
16%
Transmitted Founder Virus
16%
Sterilizing Immunity
16%
Replication-competent HIV
16%
Immunogen
16%
Infected Individual
16%
Health Relevance
16%
VRC01
16%
Protective Immunity
16%
Genetic mutation
16%
Neutralizing Activity
16%
Public Health
16%
Immunogen Design
16%
HIV Patients
16%
Escape mutation
16%
Sequential Samples
16%
Viral Glycoprotein
16%
Site-directed mutation
16%
Molecular Clone
16%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Neutralizing Antibody
58%
Antigen
33%
Monoclonal Antibody
25%
HIV/AIDS
25%
Vaccine Efficacy
25%
Gene Mutation
16%
Antibody Response
16%
Epitope
16%
Glycoprotein
16%
Neutralization
16%
Human Immunodeficiency Virus 1
16%